Top Page
BrainChip Holdings
(Sydney:BRN)
BrainChip Holdings (BRN) vs. S&P 500 (SPY)
BrainChip Holdings Business Overview & Revenue Model
BrainChip Holdings Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 240.00K | 398.01K | 232.00K | 5.07M | 1.59M | 134.60K | Gross Profit |
| 100.00K | -134.91K | 91.44K | 4.59M | 1.30M | -195.72K | EBIT |
| -28.73M | 0.00 | -28.74M | -22.42M | -19.93M | -11.64M | EBITDA |
| -28.51M | -23.67M | -27.99M | -21.41M | -19.79M | -11.36M | Net Income Common Stockholders |
| -28.88M | -24.43M | -28.88M | -22.09M | -20.98M | -29.88M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 2.05M | 20.00M | 14.34M | 23.12M | 19.37M | 19.02M | Total Assets |
| 11.81M | 23.05M | 20.18M | 29.18M | 23.78M | 22.65M | Total Debt |
| 0.00 | 1.17M | 1.70M | 2.95M | 1.80M | 3.74M | Net Debt |
| -2.05M | -18.83M | -12.65M | -20.17M | -17.57M | -15.24M | Total Liabilities |
| 1.59M | 3.22M | 3.35M | 5.46M | 4.84M | 5.93M | Stockholders Equity |
| 10.21M | 19.83M | 16.83M | 23.72M | 18.94M | 16.72M |
| Cash Flow | Free Cash Flow | ||||
| -17.66M | -15.96M | -17.66M | -19.88M | ― | ― | Operating Cash Flow |
| -17.53M | 0.00 | -17.53M | -19.69M | -13.69M | -11.17M | Investing Cash Flow |
| -132.60K | -72.65K | -132.60K | -183.52K | ― | ― | Financing Cash Flow |
| 8.84M | 22.60M | 8.84M | 25.38M | 14.19M | 23.92M |
BrainChip Holdings Technical Analysis
BrainChip Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | AU$17.01M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
59 Neutral | $10.59B | 10.09 | -6.37% | 3.05% | 7.44% | -10.67% | |
48 Neutral | $56.07M | ― | -92.68% | ― | ― | -37.93% | |
39 Underperform | AU$352.38M | ― | -46.55% | ― | 905.48% | 10.02% | |
38 Underperform | $33.81M | ― | -39.59% | ― | -55.83% | 32.05% | |
34 Underperform | $551.11M | ― | -133.28% | ― | 72.47% | 20.08% |
BrainChip Holdings Corporate Events
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically involving Peter Van Der Made, who disposed of 333,333 fully paid ordinary shares. The shares were gifted to ShareGift Australia and subject to a charity nomination to ADRA Australia, with the transaction managed through an on-market trade process. This move reflects the company’s commitment to corporate social responsibility and may influence its reputation positively among stakeholders.
BrainChip Holdings Ltd announced the issuance of 331,941 ordinary fully paid securities as of March 31, 2025. This move signifies a strategic step in strengthening the company’s financial position and potentially enhancing its market presence, reflecting its ongoing commitment to growth and innovation in the AI technology sector.
BrainChip Holdings Ltd announced the cessation of certain securities, specifically options and restricted stock units, due to unmet conditions. This development may impact the company’s capital structure and could have implications for stakeholders, as it reflects on the company’s ability to meet certain financial or operational conditions.
BrainChip Holdings Ltd is set to present its future Technology Roadmap, highlighting advancements in its Akida IP and target applications. The presentation, led by Chief Development Officer Dr. Jonathan Tapson, will provide insights into the company’s development plans and market requirements, potentially impacting BrainChip’s industry positioning and stakeholder interests.
BrainChip Holdings Ltd has announced its 2025 Annual General Meeting, highlighting the company’s commitment to aligning executive compensation with shareholder interests. The Board has designed a remuneration strategy that includes a flexible and holistic approach to attract top talent globally, with a focus on achieving high financial targets. Despite falling short of 2024 goals, the company continues to refine its compensation programs to ensure they are competitive and aligned with market practices, reflecting shareholder feedback and confidence in BrainChip’s long-term growth prospects.
BrainChip Holdings Ltd has announced a change in the director’s interest notice involving its director, Sean Hehir. The change involves the acquisition and disposal of shares and restricted stock units, resulting in Mr. Hehir holding 3,578,387 fully paid ordinary shares and 4,373,372 restricted stock units after the change. The acquisition was due to the vesting of restricted stock units, while the disposal was conducted to cover US federal and state taxes related to the vesting.
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically involving Peter Van der Made. The change includes the acquisition of 333,333 ordinary shares and the disposal of 833,333 performance rights, resulting in a new total of 157,139,156 fully paid ordinary shares. This adjustment reflects a strategic realignment of the director’s holdings, potentially impacting the company’s governance and stakeholder interests.
BrainChip Holdings has announced its Annual General Meeting scheduled for May 6, 2025, in Sydney. The company is inviting nominations for director positions, which must be submitted by March 14, 2025. This meeting is an opportunity for stakeholders to engage with the company’s strategic direction and governance, potentially impacting its industry positioning and stakeholder relations.
BrainChip Holdings announced the issuance of 273,759 fully paid ordinary shares following the vesting of Restricted Stock Units. This move, compliant with the Corporations Act, reflects BrainChip’s ongoing commitment to its operational and regulatory standards, potentially impacting its market positioning by strengthening its capital base.
BrainChip Holdings Ltd announced the issuance of 12,899,738 ordinary fully paid securities, marking a significant development in its financial operations. This move could potentially enhance the company’s market position and provide more opportunities for stakeholders to engage with its innovative AI solutions.
BrainChip Holdings Ltd has announced the issuance of 273,759 ordinary fully paid shares as a result of the vesting of Restricted Stock Units. This move is part of the company’s ongoing efforts to manage its capital structure and incentivize its workforce, potentially impacting its market position by enhancing shareholder value and aligning employee interests with company performance.
BrainChip Holdings Ltd has announced the cessation of a significant number of securities, including performance rights, options, and restricted stock units, due to unmet conditions. This development may impact the company’s capital structure and could influence investor perception, as it reflects on the company’s ability to meet certain operational or financial milestones.
BrainChip Holdings has issued 40 million fully paid ordinary shares as part of an amendment to a Put Option Agreement with LDA Group. This move, compliant with the Corporations Act, highlights the company’s strategic financial operations and could influence its market positioning by potentially increasing liquidity and investor interest.
BrainChip Holdings Ltd has issued 13 million fully paid ordinary shares to the Trustee of the BrainChip Equity Plan Trust to administer its Equity Plan, in compliance with the Corporations Act. This move supports the company’s strategic initiatives in advancing its edge AI technology, potentially strengthening its market position and offering benefits to stakeholders by enhancing operational capabilities.
BrainChip Holdings Ltd has announced the issuance of 40 million ordinary fully paid shares as part of the Fourth Amendment of the Put Option Agreement. This strategic move is expected to impact the company’s financial structure and potentially enhance its market positioning by providing additional capital for growth initiatives.
BrainChip Holdings Ltd has announced the issuance of 13,000,000 ordinary fully paid shares to the trustee of the company’s Employee Share Plan Trust. This move is part of the administration of the company’s Employee Equity Plan, which may impact the company’s stock liquidity and employee engagement strategies.
BrainChip Holdings has issued a Capital Call Notice to LDA Capital to sell up to 40 million shares, with available funding under the LDA Agreement at AUD $74.8 million. The capital raised will support the company’s product roadmap and development initiatives, including expanding its portfolio of proprietary TENNs-based models and enhancing the Akida 2.0 platform. The company is also searching for a Senior Operations Manager to enhance operational focus and support its transition into a process-driven organization, which is crucial for its growth and market penetration efforts.
BrainChip Holdings has announced its intention to explore redomiciling from Australia to the US by 2025, aiming for a listing on a US-based securities exchange. This strategic move is driven by the potential for greater access to a larger pool of technologically sophisticated investors, enhanced valuation opportunities, and reduced regulatory burdens. The transition is expected to elevate BrainChip’s market profile and provide a catalyst for growth, while offering existing shareholders the ability to hold equivalent securities on the US exchange.
BrainChip Holdings Ltd has released its corporate governance statement for the financial year ending December 31, 2024, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles, highlighting their commitment to transparency and accountability. The governance statement, approved by the board, details the extent to which BrainChip has followed the recommended practices, ensuring stakeholders are informed about the company’s governance framework and any deviations from standard practices.
BrainChip Holdings Ltd has released its Annual Report for 2024. The report includes various financial statements and disclosures, providing insights into the company’s financial performance and strategic direction. This release is significant for stakeholders as it offers a comprehensive overview of BrainChip’s financial health and operational strategies, which could influence investor decisions and market perceptions.
BrainChip Holdings Ltd reported its preliminary final results, highlighting a significant reduction in operating loss by 16% compared to the previous year, despite a substantial non-cash gain from financial assets. The company also noted a 72% increase in revenue from continuing operations, indicating positive momentum in its business activities, although it continues to operate at a loss. No dividends were paid or proposed for the year, and the financial report received an unqualified audit opinion.
BrainChip Holdings Ltd announced the issuance and transfer of unquoted equity securities, which include 270,000 options expiring on various dates at various prices and 87,500 restricted stock units. These securities are part of an employee incentive scheme and are not intended to be quoted on the ASX. This move is likely to boost the company’s employee retention and motivation strategies by aligning employee interests with company performance through stock-based compensation.
BrainChip Holdings Ltd has issued a correction to the Director’s Interests Notice for Non-Executive Director Pia Turcinov due to an administrative error in the initial filing. The company assures stakeholders that proper policies and procedures are in place to meet disclosure obligations outlined in the ASX Listing Rules. This correction underscores BrainChip’s commitment to transparency and regulatory compliance, which is crucial for maintaining trust with investors and stakeholders.